Beyond AirXAIR
Market Cap: $19.1M
About: Beyond Air Inc is a clinical-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
Employees: 107
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
238% more call options, than puts
Call options by funds: $54K | Put options by funds: $16K
5% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 22
2% less funds holding
Funds holding: 66 [Q1] → 65 (-1) [Q2]
21.09% less ownership
Funds ownership: 47.39% [Q1] → 26.3% (-21.09%) [Q2]
47% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 19
78% less capital invested
Capital invested by funds: $29.7M [Q1] → $6.49M (-$23.2M) [Q2]
100% less funds holding in top 10
Funds holding in top 10: 1 [Q1] → 0 (-1) [Q2]
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
3 analyst ratings
Roth MKM Jason White 0% 1-year accuracy 0 / 1 met price target | 388%upside $2 | Buy Reinstated | 16 Aug 2024 |
Piper Sandler Jason Bednar 45% 1-year accuracy 18 / 40 met price target | 144%upside $1 | Overweight Maintained | 7 Aug 2024 |
Piper Sandler Jason Bednar 45% 1-year accuracy 18 / 40 met price target | 754%upside $3.50 | Overweight Maintained | 25 Jun 2024 |